Literature DB >> 7944344

DNA-hydrolyzing autoantibodies.

A G Gabibov1, G V Gololobov, O I Makarevich, D V Schourov, E A Chernova, R P Yadav.   

Abstract

Catalysis by antibodies could be a frequent phenomenon if the immune system generates a sufficiently diverse number of antibody-active sites, some of which may possess catalytic activity. A catalytic antibody can be expected to do more damage than one that simply binds antigen. The best biochemical marker of systemic lupus erythematosus (SLE) is presence of autoantibodies to DNA. In the present article, we describe the DNA-hydrolyzing activity of DNA-binding autoantibodies purified from SLE patients. The substrates employed were supercoiled plasmid, radiolabeled plasmid fragments, and oligonucleotides. Hydrolysis of DNA by the antibodies was indicated by the appearance of fragments visualized by ethidium bromide staining of agarose gels or autoradiography of polyacrylamide gels. Changes in linear dichroism values were also indicative of DNA hydrolysis. The antibody activity was purified by protein A-sepharose chromatography, high-performance liquid chromatography gel filtration, and DNA-affinity chromatography. Scrupulous control studies were done to demonstrate that DNA-hydrolyzing activity really belongs to the antibodies. Purified Fab fragments showed hydrolyzing activity, whereas the Fc fragment was inactive. The specificity of DNA cleavage was investigated, and the rate parameters of hydrolysis by antibodies and conventional nucleases were compared.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944344     DOI: 10.1007/bf02787941

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  7 in total

1.  Antiidiotypic antibodies exhibiting an acetylcholinesterase abzyme activity.

Authors:  L Joron; L Izadyar; A Friboulet; M H Remy; G Pancino; A Roseto; D Thomas
Journal:  Ann N Y Acad Sci       Date:  1992-11-30       Impact factor: 5.691

2.  DNA hydrolyzing autoantibodies.

Authors:  A M Shuster; G V Gololobov; O A Kvashuk; A E Bogomolova; I V Smirnov; A G Gabibov
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

3.  Studies on a nuclease from Ustilago maydis. II. Substrate specificity and mode of action of the enzyme.

Authors:  W K Holloman
Journal:  J Biol Chem       Date:  1973-12-10       Impact factor: 5.157

4.  EcoRI endonuclease. Physical and catalytic properties of the homogenous enzyme.

Authors:  P Modrich; D Zabel
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

5.  Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody.

Authors:  S Paul; D J Volle; C M Beach; D R Johnson; M J Powell; R J Massey
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

Review 6.  Immunochemistry of DNA.

Authors:  B D Stollar
Journal:  Int Rev Immunol       Date:  1989       Impact factor: 5.311

7.  An autoantibody to single-stranded DNA: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex.

Authors:  J N Herron; X M He; D W Ballard; P R Blier; P E Pace; A L Bothwell; E W Voss; A B Edmundson
Journal:  Proteins       Date:  1991
  7 in total
  7 in total

1.  DNA binding mode of the Fab fragment of a monoclonal antibody specific for cyclobutane pyrimidine dimer.

Authors:  T Torizawa; N Yamamoto; T Suzuki; K Nobuoka; Y Komatsu; H Morioka; O Nikaido; E Ohtsuka; K Kato; I Shimada
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

Review 2.  Natural catalytic antibodies.

Authors:  S Paul
Journal:  Mol Biotechnol       Date:  1996-06       Impact factor: 2.695

Review 3.  Autoantibodies with enzymatic properties in human autoimmune diseases.

Authors:  Bharath Wootla; Sébastien Lacroix-Desmazes; Arthur E Warrington; Allan J Bieber; Srini V Kaveri; Moses Rodriguez
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

4.  Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides.

Authors:  Alena V Kundzer; Margarita V Volkova; Dimitrios P Bogdanos; Stefan Rödiger; Peter Schierack; I Generalov; Georgy A Nevinsky; Dirk Roggenbuck
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

5.  Catalytic antibodies in patients with systemic lupus erythematosus.

Authors:  Vandana Pradhan; Pallavi Pandit; Prathamesh Surve; Maxime Lecerf; Anjali Rajadhyaksha; Milind Nadkar; Prasad V Khadilkar; Durga A Chougule; Aalaap A Naigaonkar; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Kanjaksha Ghosh; Srini V Kaveri
Journal:  Eur J Rheumatol       Date:  2018-08-07

Review 6.  Catalytic Antibodies: Design, Expression, and Their Applications in Medicine.

Authors:  Daqun Zhao; Jie Chen; Xiaoyue Hu; Shujun Zhang
Journal:  Appl Biochem Biotechnol       Date:  2022-10-12       Impact factor: 3.094

Review 7.  Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside.

Authors:  Alexandre Mezentsev; Evgeny Bezsonov; Dmitry Kashirskikh; Mirza S Baig; Ali H Eid; Alexander Orekhov
Journal:  Biomedicines       Date:  2021-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.